Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$16.42 USD
-0.20 (-1.20%)
Updated May 15, 2024 04:00 PM ET
After-Market: $16.44 +0.02 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.74 | -1.58% |
Earnings Summary
For their last quarter, Day One Biopharmaceuticals (DAWN) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.67 per share. This reflects a negative earnings surprise of 7.46%. Look out for DAWN's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.74 per share, reflecting a year-over-year decrease of 21.31%.
Earnings History
Price & Consensus
Zacks News for DAWN
Here's What Could Help Day One Biopharmaceuticals, Inc. (DAWN) Maintain Its Recent Price Strength
DAWN: What are Zacks experts saying now?
Zacks Private Portfolio Services